Lectimers: Glycan-anchored scaffold libraries for targeting carbohydrate-binding
Lectimers:用于靶向碳水化合物结合的聚糖锚定支架文库
基本信息
- 批准号:8624937
- 负责人:
- 金额:$ 27.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-20 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAvidityBindingBiological MarkersBiological ProcessCarbohydratesCellsChemicalsDNADNA biosynthesisDevelopmentDiagnosticDisaccharidesDiseaseEnsureGalactose Binding LectinGalectin 1Galectin 3HumanHydroxyl RadicalIndividualLectinLibrariesLigandsMalignant NeoplasmsMethodologyMethodsModificationMonosaccharidesNucleic AcidsPeptidesPhasePlayPolymerasePolysaccharidesPositioning AttributeProtein BindingProtein FamilyProteinsReadingReagentRoleSolidSpecificitySystemTechnologyTherapeuticTherapeutic Human ExperimentationTimeUrsidae FamilyVariantVertebral columnVirus Diseasesbasecancer typecarbohydrate binding proteinchemical synthesiscostflexibilityfluorophorefunctional grouphuman diseaseimmunoregulationmembermonomernext generation sequencingnovelphosphoramiditepopulation basedpublic health relevancescaffoldsmall moleculestatisticssugartumorigenesis
项目摘要
DESCRIPTION (provided by applicant): We propose to develop a novel platform technology that will produce high-affinity and high-specificity ligands to target carbohydrate binding protein (CBPs), a diverse class of proteins which possess a wide range of biological functions, playing roles cancer tumorigeneisis, immune modulation and viral infection. Our method builds upon advances in sequencing technologies and leverages the natural, low affinity, interactions of monovalent sugars for CBPs combined with the ease of synthesis of nucleic acids. Our glycan-anchored libraries will thus possess many of the attributes of nucleic acids - in particular structural rigidity, ease of synthesis and the ease with which they can be amplified and characterized - but with the enhanced chemical functionality observed in peptides, proteins and small molecule ligands. Because these reagents are based on nucleic acids, the resulting affinity agents can be readily synthesized at relatively low cost and can be easily modified with a
variety of fluorophores or chemical moieties for diagnostic, therapeutic and research purposes.
描述(由申请人提供):我们提议开发一种新型平台技术,该技术将产生高亲和力和高特异性的配体来靶向碳水化合物结合蛋白(CBP),这是一类具有广泛生物学功能的蛋白质,在癌症中发挥作用肿瘤发生、免疫调节和病毒感染。我们的方法建立在测序技术的进步基础上,并利用了天然的、低亲和力的单价糖与CBP的相互作用以及核酸合成的便利性。因此,我们的聚糖锚定文库将具有核酸的许多属性-特别是结构刚性,易于合成以及易于扩增和表征-但具有在肽,蛋白质和小分子配体中观察到的增强的化学功能。因为这些试剂是基于核酸的,所以所得亲和剂可以以相对低的成本容易地合成,并且可以容易地用亲和剂修饰。
用于诊断、治疗和研究目的的各种荧光团或化学部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW LEVY其他文献
MATTHEW LEVY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW LEVY', 18)}}的其他基金
Lectimers: Glycan-anchored scaffold libraries for targeting carbohydrate-binding
Lectimers:用于靶向碳水化合物结合的聚糖锚定支架文库
- 批准号:
8906828 - 财政年份:2013
- 资助金额:
$ 27.72万 - 项目类别:
Lectimers: Glycan-anchored scaffold libraries for targeting carbohydrate-binding
Lectimers:用于靶向碳水化合物结合的聚糖锚定支架文库
- 批准号:
8738626 - 财政年份:2013
- 资助金额:
$ 27.72万 - 项目类别:
Targeting CNS HIV reservoirs across the blood-brain barrier
跨越血脑屏障靶向中枢神经系统艾滋病毒储存库
- 批准号:
8544744 - 财政年份:2013
- 资助金额:
$ 27.72万 - 项目类别:
Fluorescent probes for quantitation of secretory protein levels in single cells
用于定量单细胞分泌蛋白水平的荧光探针
- 批准号:
8550032 - 财政年份:2012
- 资助金额:
$ 27.72万 - 项目类别:
Fluorescent probes for quantitation of secretory protein levels in single cells
用于定量单细胞分泌蛋白水平的荧光探针
- 批准号:
8413995 - 财政年份:2012
- 资助金额:
$ 27.72万 - 项目类别:
Targeting Cancer Cells with Functionalized Nanoparticle Libraries
用功能化纳米粒子库靶向癌细胞
- 批准号:
8080080 - 财政年份:2011
- 资助金额:
$ 27.72万 - 项目类别:
Targeting Cancer Cells with Functionalized Nanoparticle Libraries
用功能化纳米粒子库靶向癌细胞
- 批准号:
8319439 - 财政年份:2011
- 资助金额:
$ 27.72万 - 项目类别:
Targeting Cancer Cells with Functionalized Nanoparticle Libraries
用功能化纳米粒子库靶向癌细胞
- 批准号:
8504814 - 财政年份:2011
- 资助金额:
$ 27.72万 - 项目类别:
Engineering Sortase Variants for Intracellular and Cell Surface Labeling
用于细胞内和细胞表面标记的工程分选酶变体
- 批准号:
8539803 - 财政年份:2009
- 资助金额:
$ 27.72万 - 项目类别:
Engineering Sortase Variants for Intracellular and Cell Surface Labeling
用于细胞内和细胞表面标记的工程分选酶变体
- 批准号:
8136676 - 财政年份:2009
- 资助金额:
$ 27.72万 - 项目类别:
相似海外基金
Avidityに着目した食物経口免疫療法の出口戦略
食物口服免疫疗法的退出策略以亲和力为重点
- 批准号:
24K19255 - 财政年份:2024
- 资助金额:
$ 27.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Modulating Fibrinolysis Dynamics by Leveraging Multivalent Avidity to Control Enzyme Activity
通过利用多价亲和力控制酶活性来调节纤维蛋白溶解动力学
- 批准号:
10635496 - 财政年份:2023
- 资助金额:
$ 27.72万 - 项目类别:
Antibody avidity maturation as index for Immune resilience against SARS-CoV-2
抗体亲合力成熟作为针对 SARS-CoV-2 免疫恢复的指标
- 批准号:
22K15927 - 财政年份:2022
- 资助金额:
$ 27.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel DNA vaccine that delivers long lasting immunity by stimulating high avidity CD8 T cells and strong neutralising antibodies
一种新型 DNA 疫苗,通过刺激高亲和力 CD8 T 细胞和强中和抗体来提供持久的免疫力
- 批准号:
73437 - 财政年份:2020
- 资助金额:
$ 27.72万 - 项目类别:
Collaborative R&D
RAPID: Effect of Avidity on Association of Fusion Inhibitory Peptides with the HRN Domain of SARS-CoV-2 Spike Protein
RAPID:亲合力对融合抑制肽与 SARS-CoV-2 刺突蛋白 HRN 结构域关联的影响
- 批准号:
2031167 - 财政年份:2020
- 资助金额:
$ 27.72万 - 项目类别:
Standard Grant
An acoustofluidic avidity cytometer for massive parallel profiling single autoreactive T cell in autoimmune disease
用于大规模平行分析自身免疫性疾病中单个自身反应性 T 细胞的声流控亲和细胞仪
- 批准号:
10002377 - 财政年份:2020
- 资助金额:
$ 27.72万 - 项目类别:
The effect of oral immunotherapy on class switching and change in avidity of allergen-specific immunoglobulin
口服免疫疗法对类别转换和过敏原特异性免疫球蛋白亲合力变化的影响
- 批准号:
16K19648 - 财政年份:2016
- 资助金额:
$ 27.72万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
UNS:Thermal control of avidity for separation of biologicals
UNS:生物制品分离亲合力的热控制
- 批准号:
1511227 - 财政年份:2015
- 资助金额:
$ 27.72万 - 项目类别:
Standard Grant